SABCS 2020

Tucatinib | Breast Cancer | Abstract 117

Tucatinib vs placebo in combination with trastuzumab and capecitabine for patients with locally advanced unresectable or HER2-positive metastatic breast cancer (HER2CLIMB): outcomes by hormone receptor status

Tucatinib | Breast Cancer | Poster PD13-04

Impact of tucatinib on health-related quality of life in patients with HER2+ metastatic breast cancer with active brain metastases

Tucatinib | Research | Abstract 1290

Tucatinib potentiates the activity of the antibody-drug conjugate T-DM1 in preclinical models of HER2-positive breast cancer

Tucatinib | Breast Cancer | Abstract 109

HER2CLIMB-02 TIP: A randomized, double-blind, phase 3 study of tucatinib or placebo with T-DM1 for unresectable locally-advanced or metastatic HER2+ breast cancer

Ladiratuzumab vedotin | Breast Cancer | Abstract 410

SGNLVA-001 TIP: A phase 1 open-label dose escalation and expansion study of SGN-LIV1A administered weekly in breast cancer

HEOR | Breast Cancer | Abstract 130

Real world treatment patterns and healthcare resource utilization among HER2+ metastatic breast cancer patients with and without brain metastases: a retrospective cohort study